Neuralink

Neuralink is a neurotechnology company founded by Elon Musk and others to develop high-bandwidth brain-computer interfaces (BCIs). The company's primary goal is to create implantable neural devices that can record and transmit signals between the brain and external computers, initially targeting restoration of motor function and communication in individuals with severe paralysis or neurological conditions.

The company has conducted animal testing and received FDA approval for human trials. In January 2024, Neuralink announced its first successful human implant, a major milestone in the field. The technology uses a surgically implanted array of electrodes to interface with neural tissue, with the long-term vision of enabling direct brain-to-computer communication.

Neuralink operates within the broader context of neurotechnology and brain-computer interface research, competing with and complementing other BCI efforts. The company has attracted significant investment and media attention due to both the ambition of its goals and the prominence of its founder.